Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.He,
W.Dang,
C.Abe,
K.Tsuda,
M.Inoue,
S.Watanabe,
N.Kobayashi,
T.Kigawa,
T.Matsuda,
T.Yabuki,
M.Aoki,
E.Seki,
T.Harada,
Y.Tomabechi,
T.Terada,
M.Shirouzu,
A.Tanaka,
P.Güntert,
Y.Muto,
and
S.Yokoyama
(2009).
Solution structure of the RNA binding domain in the human muscleblind-like protein 2.
|
| |
Protein Sci, 18,
80-91.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Li,
Q.Liu,
X.Hu,
D.Feng,
S.Xiang,
Z.He,
X.Hu,
J.Zhou,
X.Ding,
C.Zhou,
and
J.Zhang
(2009).
Human ZCCHC12 activates AP-1 and CREB signaling as a transcriptional co-activator.
|
| |
Acta Biochim Biophys Sin (Shanghai), 41,
535-544.
|
 |
|
|
|
|
 |
V.V.Shvadchak,
A.S.Klymchenko,
H.de Rocquigny,
and
Y.Mély
(2009).
Sensing peptide-oligonucleotide interactions by a two-color fluorescence label: application to the HIV-1 nucleocapsid protein.
|
| |
Nucleic Acids Res, 37,
e25.
|
 |
|
|
|
|
 |
B.Berkhout,
R.Gorelick,
M.F.Summers,
Y.Mély,
and
J.L.Darlix
(2008).
6th international symposium on retroviral nucleocapsid.
|
| |
Retrovirology, 5,
21.
|
 |
|
|
|
|
 |
P.L.Hayes,
B.L.Lytle,
B.F.Volkman,
and
F.C.Peterson
(2008).
The solution structure of ZNF593 from Homo sapiens reveals a zinc finger in a predominantly unstructured protein.
|
| |
Protein Sci, 17,
571-576.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Bombarda,
E.Grell,
B.P.Roques,
and
Y.Mély
(2007).
Molecular mechanism of the Zn2+-induced folding of the distal CCHC finger motif of the HIV-1 nucleocapsid protein.
|
| |
Biophys J, 93,
208-217.
|
 |
|
|
|
|
 |
F.He,
T.Umehara,
K.Tsuda,
M.Inoue,
T.Kigawa,
T.Matsuda,
T.Yabuki,
M.Aoki,
E.Seki,
T.Terada,
M.Shirouzu,
A.Tanaka,
S.Sugano,
Y.Muto,
and
S.Yokoyama
(2007).
Solution structure of the zinc finger HIT domain in protein FON.
|
| |
Protein Sci, 16,
1577-1587.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Eshete,
M.T.Marchbank,
S.L.Deutscher,
B.Sproat,
G.Leszczynska,
A.Malkiewicz,
and
P.F.Agris
(2007).
Specificity of phage display selected peptides for modified anticodon stem and loop domains of tRNA.
|
| |
Protein J, 26,
61-73.
|
 |
|
|
|
|
 |
S.Tang,
J.Zhao,
J.J.Storhoff,
P.J.Norris,
R.F.Little,
R.Yarchoan,
S.L.Stramer,
T.Patno,
M.Domanus,
A.Dhar,
C.A.Mirkin,
and
I.K.Hewlett
(2007).
Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen.
|
| |
J Acquir Immune Defic Syndr, 46,
231-237.
|
 |
|
|
|
|
 |
V.Németh-Pongrácz,
O.Barabás,
M.Fuxreiter,
I.Simon,
I.Pichová,
M.Rumlová,
H.Zábranská,
D.Svergun,
M.Petoukhov,
V.Harmat,
E.Klement,
E.Hunyadi-Gulyás,
K.F.Medzihradszky,
E.Kónya,
and
B.G.Vértessy
(2007).
Flexible segments modulate co-folding of dUTPase and nucleocapsid proteins.
|
| |
Nucleic Acids Res, 35,
495-505.
|
 |
|
|
|
|
 |
C.Gabus,
R.Ivanyi-Nagy,
J.Depollier,
A.Bucheton,
A.Pelisson,
and
J.L.Darlix
(2006).
Characterization of a nucleocapsid-like region and of two distinct primer tRNALys,2 binding sites in the endogenous retrovirus Gypsy.
|
| |
Nucleic Acids Res, 34,
5764-5777.
|
 |
|
|
|
|
 |
K.B.Turner,
N.A.Hagan,
and
D.Fabris
(2006).
Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Psi-RNA.
|
| |
Nucleic Acids Res, 34,
1305-1316.
|
 |
|
|
|
|
 |
D.R.Morcock,
J.A.Thomas,
T.D.Gagliardi,
R.J.Gorelick,
J.D.Roser,
E.N.Chertova,
J.W.Bess,
D.E.Ott,
Q.J.Sattentau,
I.Frank,
M.Pope,
J.D.Lifson,
L.E.Henderson,
and
B.J.Crise
(2005).
Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.
|
| |
J Virol, 79,
1533-1542.
|
 |
|
|
|
|
 |
V.D'Souza,
and
M.F.Summers
(2005).
How retroviruses select their genomes.
|
| |
Nat Rev Microbiol, 3,
643-655.
|
 |
|
|
|
|
 |
G.Cosa,
E.J.Harbron,
Y.Zeng,
H.W.Liu,
D.B.O'Connor,
C.Eta-Hosokawa,
K.Musier-Forsyth,
and
P.F.Barbara
(2004).
Secondary structure and secondary structure dynamics of DNA hairpins complexed with HIV-1 NC protein.
|
| |
Biophys J, 87,
2759-2767.
|
 |
|
|
|
|
 |
I.Onn,
N.Milman-Shtepel,
and
J.Shlomai
(2004).
Redox potential regulates binding of universal minicircle sequence binding protein at the kinetoplast DNA replication origin.
|
| |
Eukaryot Cell, 3,
277-287.
|
 |
|
|
|
|
 |
J.L.Newman,
E.W.Butcher,
D.T.Patel,
Y.Mikhaylenko,
and
M.F.Summers
(2004).
Flexibility in the P2 domain of the HIV-1 Gag polyprotein.
|
| |
Protein Sci, 13,
2101-2107.
|
 |
|
|
|
|
 |
J.M.Barletta,
D.C.Edelman,
and
N.T.Constantine
(2004).
Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.
|
| |
Am J Clin Pathol, 122,
20-27.
|
 |
|
|
|
|
 |
M.R.Chance,
A.Fiser,
A.Sali,
U.Pieper,
N.Eswar,
G.Xu,
J.E.Fajardo,
T.Radhakannan,
and
N.Marinkovic
(2004).
High-throughput computational and experimental techniques in structural genomics.
|
| |
Genome Res, 14,
2145-2154.
|
 |
|
|
|
|
 |
S.Ramboarina,
S.Druillennec,
N.Morellet,
S.Bouaziz,
and
B.P.Roques
(2004).
Target specificity of human immunodeficiency virus type 1 NCp7 requires an intact conformation of its CCHC N-terminal zinc finger.
|
| |
J Virol, 78,
6682-6687.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.F.McGrath,
J.S.Buckman,
T.D.Gagliardi,
W.J.Bosche,
L.V.Coren,
and
R.J.Gorelick
(2003).
Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid protein.
|
| |
J Virol, 77,
8524-8531.
|
 |
|
|
|
|
 |
E.G.Lee,
A.Alidina,
C.May,
and
M.L.Linial
(2003).
Importance of basic residues in binding of rous sarcoma virus nucleocapsid to the RNA packaging signal.
|
| |
J Virol, 77,
2010-2020.
|
 |
|
|
|
|
 |
N.Lee,
R.J.Gorelick,
and
K.Musier-Forsyth
(2003).
Zinc finger-dependent HIV-1 nucleocapsid protein-TAR RNA interactions.
|
| |
Nucleic Acids Res, 31,
4847-4855.
|
 |
|
|
|
|
 |
D.Kern
(2002).
Cutting the leash.
|
| |
Nat Struct Biol, 9,
496-497.
|
 |
|
|
|
|
 |
J.Guo,
T.Wu,
B.F.Kane,
D.G.Johnson,
L.E.Henderson,
R.J.Gorelick,
and
J.G.Levin
(2002).
Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.
|
| |
J Virol, 76,
4370-4378.
|
 |
|
|
|
|
 |
S.Shim,
N.Bae,
and
J.K.Han
(2002).
Bone morphogenetic protein-4-induced activation of Xretpos is mediated by Smads and Olf-1/EBF associated zinc finger (OAZ).
|
| |
Nucleic Acids Res, 30,
3107-3117.
|
 |
|
|
|
|
 |
X.Gao,
D.J.Rowley,
X.Gai,
and
D.F.Voytas
(2002).
Ty5 gag mutations increase retrotransposition and suggest a role for hydrogen bonding in the function of the nucleocapsid zinc finger.
|
| |
J Virol, 76,
3240-3247.
|
 |
|
|
|
|
 |
I.A.Topol,
C.McGrath,
E.Chertova,
C.Dasenbrock,
W.R.Lacourse,
M.A.Eissenstat,
S.K.Burt,
L.E.Henderson,
and
J.R.Casas-Finet
(2001).
Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.
|
| |
Protein Sci, 10,
1434-1445.
|
 |
|
|
|
|
 |
J.Gonsky,
E.Bacharach,
and
S.P.Goff
(2001).
Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.
|
| |
J Virol, 75,
2616-2626.
|
 |
|
|
|
|
 |
K.Shigemoto,
J.Brennan,
E.Walls,
C.J.Watson,
D.Stott,
P.W.Rigby,
and
A.D.Reith
(2001).
Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting.
|
| |
Nucleic Acids Res, 29,
4079-4088.
|
 |
|
|
|
|
 |
M.Negroni,
and
H.Buc
(2001).
Mechanisms of retroviral recombination.
|
| |
Annu Rev Genet, 35,
275-302.
|
 |
|
|
|
|
 |
D.J.Klein,
P.E.Johnson,
E.S.Zollars,
R.N.De Guzman,
and
M.F.Summers
(2000).
The NMR structure of the nucleocapsid protein from the mouse mammary tumor virus reveals unusual folding of the C-terminal zinc knuckle.
|
| |
Biochemistry, 39,
1604-1612.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.W.Buchko,
N.J.Hess,
V.Bandaru,
S.S.Wallace,
and
M.A.Kennedy
(2000).
Spectroscopic studies of zinc(II)- and cobalt(II)-associated Escherichia coli formamidopyrimidine-DNA glycosylase: extended X-ray absorption fine structure evidence for a metal-binding domain.
|
| |
Biochemistry, 39,
12441-12449.
|
 |
|
|
|
|
 |
J.Guo,
T.Wu,
J.Anderson,
B.F.Kane,
D.G.Johnson,
R.J.Gorelick,
L.E.Henderson,
and
J.G.Levin
(2000).
Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer.
|
| |
J Virol, 74,
8980-8988.
|
 |
|
|
|
|
 |
P.E.Johnson,
R.B.Turner,
Z.R.Wu,
L.Hairston,
J.Guo,
J.G.Levin,
and
M.F.Summers
(2000).
A mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid protein during reverse transcription.
|
| |
Biochemistry, 39,
9084-9091.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Vuilleumier,
E.Bombarda,
N.Morellet,
D.Gérard,
B.P.Roques,
and
Y.Mély
(1999).
Nucleic acid sequence discrimination by the HIV-1 nucleocapsid protein NCp7: a fluorescence study.
|
| |
Biochemistry, 38,
16816-16825.
|
 |
|
|
|
|
 |
E.Bombarda,
A.Ababou,
C.Vuilleumier,
D.Gérard,
B.P.Roques,
E.Piémont,
and
Y.Mély
(1999).
Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids.
|
| |
Biophys J, 76,
1561-1570.
|
 |
|
|
|
|
 |
S.Campbell,
and
A.Rein
(1999).
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
|
| |
J Virol, 73,
2270-2279.
|
 |
|
|
|
|
 |
A.D.Frankel,
and
J.A.Young
(1998).
HIV-1: fifteen proteins and an RNA.
|
| |
Annu Rev Biochem, 67,
1.
|
 |
|
|
|
|
 |
A.Y.Louie,
and
T.J.Meade
(1998).
A cobalt complex that selectively disrupts the structure and function of zinc fingers.
|
| |
Proc Natl Acad Sci U S A, 95,
6663-6668.
|
 |
|
|
|
|
 |
C.Gabus,
D.Ficheux,
M.Rau,
G.Keith,
S.Sandmeyer,
and
J.L.Darlix
(1998).
The yeast Ty3 retrotransposon contains a 5'-3' bipartite primer-binding site and encodes nucleocapsid protein NCp9 functionally homologous to HIV-1 NCp7.
|
| |
EMBO J, 17,
4873-4880.
|
 |
|
|
|
|
 |
E.Le Cam,
D.Coulaud,
E.Delain,
P.Petitjean,
B.P.Roques,
D.Gérard,
E.Stoylova,
C.Vuilleumier,
S.P.Stoylov,
and
Y.Mély
(1998).
Properties and growth mechanism of the ordered aggregation of a model RNA by the HIV-1 nucleocapsid protein: an electron microscopy investigation.
|
| |
Biopolymers, 45,
217-229.
|
 |
|
|
|
|
 |
E.N.Chertova,
B.P.Kane,
C.McGrath,
D.G.Johnson,
R.C.Sowder,
L.O.Arthur,
and
L.E.Henderson
(1998).
Probing the topography of HIV-1 nucleocapsid protein with the alkylating agent N-ethylmaleimide.
|
| |
Biochemistry, 37,
17890-17897.
|
 |
|
|
|
|
 |
M.Yeager,
E.M.Wilson-Kubalek,
S.G.Weiner,
P.O.Brown,
and
A.Rein
(1998).
Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.
|
| |
Proc Natl Acad Sci U S A, 95,
7299-7304.
|
 |
|
|
|
|
 |
N.J.Hess,
G.W.Buchko,
S.D.Conradson,
F.J.Espinosa,
S.Ni,
B.D.Thrall,
and
M.A.Kennedy
(1998).
Human nucleotide excision repair protein XPA: extended X-ray absorption fine-structure evidence for a metal-binding domain.
|
| |
Protein Sci, 7,
1970-1975.
|
 |
|
|
|
|
 |
R.N.De Guzman,
R.B.Turner,
and
M.F.Summers
(1998).
Protein-RNA recognition.
|
| |
Biopolymers, 48,
181-195.
|
 |
|
|
|
|
 |
Y.Gao,
K.Kaluarachchi,
and
D.P.Giedroc
(1998).
Solution structure and backbone dynamics of Mason-Pfizer monkey virus (MPMV) nucleocapsid protein.
|
| |
Protein Sci, 7,
2265-2280.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Kodera,
K.Sato,
T.Tsukahara,
H.Komatsu,
T.Maeda,
and
T.Kohno
(1998).
High-resolution solution NMR structure of the minimal active domain of the human immunodeficiency virus type-2 nucleocapsid protein.
|
| |
Biochemistry, 37,
17704-17713.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Guo,
L.E.Henderson,
J.Bess,
B.Kane,
and
J.G.Levin
(1997).
Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA.
|
| |
J Virol, 71,
5178-5188.
|
 |
|
|
|
|
 |
J.Q.Wu,
A.H.Maki,
A.Ozarowski,
M.A.Urbaneja,
L.E.Henderson,
and
J.R.Casas-Finet
(1997).
Fluorescence, phosphorescence, and optically detected magnetic resonance studies of the nucleic acid association of the nucleocapsid protein of the murine leukemia virus.
|
| |
Biochemistry, 36,
6115-6123.
|
 |
|
|
|
|
 |
P.J.Tummino,
P.J.Harvey,
T.McQuade,
J.Domagala,
R.Gogliotti,
J.Sanchez,
Y.Song,
and
D.Hupe
(1997).
The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities.
|
| |
Antimicrob Agents Chemother, 41,
394-400.
|
 |
|
|
|
|
 |
S.P.Stoylov,
C.Vuilleumier,
E.Stoylova,
H.De Rocquigny,
B.P.Roques,
D.Gérard,
and
Y.Mély
(1997).
Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein.
|
| |
Biopolymers, 41,
301-312.
|
 |
|
|
|
|
 |
W.G.Rice,
D.C.Baker,
C.A.Schaeffer,
L.Graham,
M.Bu,
S.Terpening,
D.Clanton,
R.Schultz,
J.P.Bader,
R.W.Buckheit,
L.Field,
P.K.Singh,
and
J.A.Turpin
(1997).
Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins.
|
| |
Antimicrob Agents Chemother, 41,
419-426.
|
 |
|
|
|
|
 |
Y.Zhang,
and
E.Barklis
(1997).
Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.
|
| |
J Virol, 71,
6765-6776.
|
 |
|
|
|
|
 |
A.Rein,
D.E.Ott,
J.Mirro,
L.O.Arthur,
W.Rice,
and
L.E.Henderson
(1996).
Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein.
|
| |
J Virol, 70,
4966-4972.
|
 |
|
|
|
|
 |
L.M.Newby,
and
F.R.Jackson
(1996).
Regulation of a specific circadian clock output pathway by lark, a putative RNA-binding protein with repressor activity.
|
| |
J Neurobiol, 31,
117-128.
|
 |
|
|
|
|
 |
P.J.Tummino,
J.D.Scholten,
P.J.Harvey,
T.P.Holler,
L.Maloney,
R.Gogliotti,
J.Domagala,
and
D.Hupe
(1996).
The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity.
|
| |
Proc Natl Acad Sci U S A, 93,
969-973.
|
 |
|
|
|
|
 |
Q.Yu,
and
J.L.Darlix
(1996).
The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo.
|
| |
J Virol, 70,
5791-5798.
|
 |
|
|
|
|
 |
R.J.Gorelick,
D.J.Chabot,
D.E.Ott,
T.D.Gagliardi,
A.Rein,
L.E.Henderson,
and
L.O.Arthur
(1996).
Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.
|
| |
J Virol, 70,
2593-2597.
|
 |
|
|
|
|
 |
R.Khan,
H.O.Chang,
K.Kaluarachchi,
and
D.P.Giedroc
(1996).
Interaction of retroviral nucleocapsid proteins with transfer RNAPhe: a lead ribozyme and 1H NMR study.
|
| |
Nucleic Acids Res, 24,
3568-3575.
|
 |
|
|
|
|
 |
W.G.Rice,
and
J.A.Turpin
(1996).
Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy.
|
| |
Rev Med Virol, 6,
187-199.
|
 |
|
|
|
|
 |
W.Wu,
L.E.Henderson,
T.D.Copeland,
R.J.Gorelick,
W.J.Bosche,
A.Rein,
and
J.G.Levin
(1996).
Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract.
|
| |
J Virol, 70,
7132-7142.
|
 |
|
|
|
|
 |
Y.Mély,
H.De Rocquigny,
N.Morellet,
B.P.Roques,
and
D.Gérad
(1996).
Zinc binding to the HIV-1 nucleocapsid protein: a thermodynamic investigation by fluorescence spectroscopy.
|
| |
Biochemistry, 35,
5175-5182.
|
 |
|
|
|
|
 |
A.Klug
(1995).
Gene regulatory proteins and their interaction with DNA.
|
| |
Ann N Y Acad Sci, 758,
143-160.
|
 |
|
|
|
|
 |
M.Ottmann,
C.Gabus,
and
J.L.Darlix
(1995).
The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity.
|
| |
J Virol, 69,
1778-1784.
|
 |
|
|
|
|
 |
R.D.Berkowitz,
A.Ohagen,
S.Höglund,
and
S.P.Goff
(1995).
Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.
|
| |
J Virol, 69,
6445-6456.
|
 |
|
|
|
|
 |
A.Rein,
D.P.Harvin,
J.Mirro,
S.M.Ernst,
and
R.J.Gorelick
(1994).
Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus.
|
| |
J Virol, 68,
6124-6129.
|
 |
|
|
|
|
 |
J.Dannull,
A.Surovoy,
G.Jung,
and
K.Moelling
(1994).
Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.
|
| |
EMBO J, 13,
1525-1533.
|
 |
|
|
|
|
 |
N.Sheng,
and
S.Erickson-Viitanen
(1994).
Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent.
|
| |
J Virol, 68,
6207-6214.
|
 |
|
|
|
|
 |
S.D.Malley,
J.M.Grange,
F.Hamedi-Sangsari,
and
J.R.Vila
(1994).
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
|
| |
Proc Natl Acad Sci U S A, 91,
11017-11021.
|
 |
|
|
|
|
 |
F.Dib-Hajj,
R.Khan,
and
D.P.Giedroc
(1993).
Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity.
|
| |
Protein Sci, 2,
231-243.
|
 |
|
|
|
|
 |
R.D.Berkowitz,
J.Luban,
and
S.P.Goff
(1993).
Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
|
| |
J Virol, 67,
7190-7200.
|
 |
|
|
|
|
 |
R.J.Gorelick,
D.J.Chabot,
A.Rein,
L.E.Henderson,
and
L.O.Arthur
(1993).
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.
|
| |
J Virol, 67,
4027-4036.
|
 |
|
|
|
|
 |
T.Dorfman,
J.Luban,
S.P.Goff,
W.A.Haseltine,
and
H.G.Göttlinger
(1993).
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
|
| |
J Virol, 67,
6159-6169.
|
 |
|
|
|
|
 |
T.L.South,
and
M.F.Summers
(1993).
Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC.
|
| |
Protein Sci, 2,
3.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.G.Rice,
C.A.Schaeffer,
L.Graham,
M.Bu,
J.S.McDougal,
S.L.Orloff,
F.Villinger,
M.Young,
S.Oroszlan,
and
M.R.Fesen
(1993).
The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.
|
| |
Proc Natl Acad Sci U S A, 90,
9721-9724.
|
 |
|
|
|
|
 |
Y.Mély,
E.Piémont,
M.Sorinas-Jimeno,
H.de Rocquigny,
N.Jullian,
N.Morellet,
B.P.Roques,
and
D.Gérard
(1993).
Structural and dynamic characterization of the aromatic amino acids of the human immunodeficiency virus type I nucleocapsid protein zinc fingers and their involvement in heterologous tRNA(Phe) binding: a steady-state and time-resolved fluorescence study.
|
| |
Biophys J, 65,
1513-1522.
|
 |
|
|
|
|
 |
M.R.Chance,
I.Sagi,
M.D.Wirt,
S.M.Frisbie,
E.Scheuring,
E.Chen,
J.W.Bess,
L.E.Henderson,
L.O.Arthur,
and
T.L.South
(1992).
Extended x-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc.
|
| |
Proc Natl Acad Sci U S A, 89,
10041-10045.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|